Oxford Drug Design, an advanced spinout from Oxford University, is an innovative biotechnology company discovering and developing novel therapeutics supported by pioneering computational methods. We are discovering new drugs with differentiated modes of action against challenging diseases with high unmet medical need. Based on a core competence platform in tRNA synthetase enzymes and distinctive AI/ML methods, our pipeline expansion is focused on oncology. Our differentiated drug discovery platform has been validated by the rapid discovery of novel therapeutic candidates with highly innovative chemical scaffolds and modes of action against urgent pathogens.